
Mass tort cost per signed retainer benchmarks
These are the current cost-per-signed-retainer (CPR) and signed-rate benchmarks for 14 active mass torts, covering Q1 2026 and current as of March 31, 2026. The national median CPR is $3,850. Figures draw on a panel of 140 plaintiff-side firms representing roughly $180M of annual mass tort lead spend, cross-referenced against published industry surveys. Every value below is either taken from that dataset or marked n/a with a reason — nothing is estimated, smoothed, or filled in.
Data as of Updated Q1 2026 releaseLatest published release; the next quarterly release has not been published yet
National median cost per signed retainer · Q1 2026
$3,850
+24% versus $3,100 in Q4 2024, the prior published national median.
Change is measured against the Q4 2024 benchmark, the prior published national median. The intervening quarters are not held in the dataset, so a true quarter-over-quarter change is not computable.
- TCPA compliance premiums on consent-verified lead flow
- Rising digital ad CPMs
- Tighter MDL-level case qualification criteria
- Sample size
- n/a — Panel totals (140 firms, $180M annual spend) are published, but the count of firms contributing to the national median specifically is not tracked in the published dataset.
- Confidence interval
- n/a — Not computable. The published dataset carries interquartile ranges, not the per-observation values a confidence interval requires.
Unverified
No third party has reviewed this methodology or the underlying data. Mass Tort Marketing Agency sells the leads these figures price.
What third-party verification would involveThe ledger
CPR by tort — Q1 2026
Sort any column, filter by status or qualification tier, and click a tort for its own page with criteria, trend, and exports. Rows refresh as a complete set each quarter.
Showing 14 of 14 torts
CPR is the interquartile low and high bound. Per-tort medians, sample sizes, and confidence intervals are marked n/a where the dataset does not carry them — hover any n/a, or open “Why some cells read n/a” below, for the reason.
| CPR median | Sample size | 95% CI | Row updated | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Rideshareassault/injury | Active | $950 | n/a | $1,400 | 18–24% | Low | n/a | n/a | |
| Hair Relaxeruterine and ovarian cancer | Active | $1,150 | n/a | $1,800 | 14–18% | Medium | n/a | n/a | |
| Roundupnon-Hodgkin lymphoma | Active | $1,400 | n/a | $2,100 | 12–17% | Medium | n/a | n/a | |
| Suboxonetooth decay and dental injury | Active | $1,800 | n/a | $2,600 | 11–16% | Medium | n/a | n/a | |
| Depo Proverameningioma | Active | $2,200 | n/a | $3,100 | 10–14% | Medium-High | n/a | n/a | |
| Camp LejeunePACT Act water contamination | Active | $2,400 | n/a | $3,600 | 14–20% | Medium | n/a | n/a | |
| AFFFfirefighting foam, PFAS cancer | Active | $2,800 | n/a | $4,200 | 9–14% | High | n/a | n/a | |
| NECbaby formula | Active | $3,100 | n/a | $4,800 | 8–13% | High | n/a | n/a | |
| Hernia Meshimplant complications | Active | $3,400 | n/a | $4,900 | 9–14% | Medium-High | n/a | n/a | |
| Bard PowerPortcatheter fracture and migration | Active | $3,800 | n/a | $5,400 | 8–12% | High | n/a | n/a | |
| OzempicGLP-1 gastroparesis | Active | $4,200 | n/a | $6,100 | 7–11% | High | n/a | n/a | |
| Olympus ScopeCRE infection, MAJ-891 recall | Active | $5,200 | n/a | $7,600 | 6–10% | Very High | n/a | n/a | |
| Oxbrytasickle cell disease | Active | $5,800 | n/a | $8,400 | 6–9% | Very High | n/a | n/a | |
| PFASpersonal injury, non-AFFF residential | Active | $7,500 | n/a | $11,500 | 4–8% | Very High | n/a | n/a |
Why some cells read n/a
- CPR median
- Per-tort medians are not published. The dataset carries the interquartile low and high bounds for each tort; only the national median is published as a point value.
- Sample size
- Per-tort sample sizes are not broken out in the published dataset. The panel total (140 firms, $180M of annual mass tort lead spend across 16 active tort categories) is published at the panel level only, so the number of firms and the spend basis behind any single row cannot be stated.
- Confidence interval
- Not computable from the published dataset. Benchmarks are published as trimmed interquartile ranges, and the per-observation values a confidence interval requires are not retained in the published figures.
- Row updated
- Rows are refreshed as a complete set each release, so every row carries the release publication date rather than an independent per-row date.
Method
How these numbers are calculated
The short version. The methodology page carries the full definitions, the panel description, the known limitations, and a dated changelog.
What counts as a signed retainer
A signed retainer that survives the 30-day falloff window: the claimant has signed, cleared medical-record verification, and remains engaged with the firm after 30 days. A raw signed count taken before falloff overstates real performance by 15–28% on average, so it is not what these figures measure.
What counts as qualifying spend
Media and lead-acquisition spend reported by panel firms against the tort in question, for the quarter in question. Spend is attributed to the quarter it was incurred, not the quarter a resulting retainer was signed.
How falloff is treated
Falloff is netted out of the denominator before CPR is computed, not reported alongside it. A retainer that falls off inside 30 days is not counted as signed, so the CPR shown already carries the cost of the leads that produced it.
What is excluded
Observations above the 95th percentile and below the 5th percentile are trimmed before the interquartile range is taken, so a single catastrophically underperforming or anomalously cheap campaign cannot move a published band.
Formula. CPR = qualifying spend ÷ signed retainers surviving the 30-day falloff window. Bands are trimmed interquartile ranges across panel firms, not averages. Per-tort medians, per-row sample sizes, and confidence intervals are not currently derivable from the published dataset and are shown as n/a rather than approximated.
Using the ledger
Reading cost per signed retainer by tort
Cost per lead answers a vendor’s question: what was sold. Cost per signed retainer answers the firm’s: what was signed, what stayed signed, and what it cost to get there. It is the only acquisition metric that reconciles with a contingency-fee P&L.
From cost per lead to cost per retainer
Every stage between the ad and the retained case multiplies, so the conversion is a single formula: CPR = CPL ÷ (signed rate × (1 − falloff rate)).
Illustrative arithmetic, not panel data: a firm buys 200 leads at $95 ($19,000). Intake signs 22 of them, an 11% signed rate. Three fall off inside 30 days after failed medical-record verification. Nineteen retained cases on $19,000 of spend is a CPR of $1,000 — not the $95 the vendor advertised. A firm that tracked only CPL would not know whether the campaign was profitable until settlements arrived years later.
The same math is why intake improvements compound. Raising the signed rate lowers CPR on every lead the firm already buys, at the same ad spend and the same CPL; renegotiating price only affects the next contract.
Why CPR differs so much between torts
Four factors move a tort’s band. Breadth of criteria: a tort open to anyone with a documented qualifying event converts far more of its leads than one that requires a narrow, biopsy-confirmed diagnosis. Size of the claimant pool: large, familiar populations make acquisition funnels efficient. Qualification difficulty: product identification and medical-record requirements raise both screening cost and falloff. Litigation maturity: as MDL leadership tightens criteria and more firms compete for the same claimants, the cost of a signed retainer rises.
Variance inside a band is mostly the firm’s own. Two firms buying the same leads for the same tort in the same week can land far apart because of intake: speed to first contact, a structured multi-touch follow-up cadence, and qualification depth on the first call. A firm that blames the vendor for an intake problem tends to buy the same problem from a new vendor next quarter.
How to use these benchmarks
Compute your own CPR per vendor, per tort, per quarter, on retainers that survived 30 days, and compare each cell with the tort’s band above. A result well above the band with no intake explanation is a vendor question; a result above the band across every vendor is an intake question. For what to ask a vendor once you have the number, see how to choose a mass tort marketing agency; for the intake side, see mass tort intake.
Questions
Cost per signed retainer, answered
- Why is cost per signed retainer higher than cost per lead?
- Cost per lead only captures what a firm paid a vendor for a raw inquiry. Cost per signed retainer captures what it paid for a claimant who actually signed, survived medical-record review and conflict checks, and stayed engaged past the 30-day falloff window. The stages multiply rather than add: CPR = CPL ÷ (signed rate × (1 − falloff rate)). As illustrative arithmetic, a $65 lead with a 7% signed rate and 22% falloff works out to roughly $1,200 per retained case.
- Which mass torts have the lowest and highest cost per signed retainer?
- In the Q1 2026 benchmark, the lowest-CPR torts are Rideshare (Uber/Lyft assault and injury) at $950–$1,400 and Hair Relaxer (uterine and ovarian cancer) at $1,150–$1,800, and the highest is PFAS personal injury (non-AFFF residential) at $7,500–$11,500. Higher-volume torts with broad criteria are cheaper per signed retainer because acquisition funnels are efficient and qualification is less restrictive; torts that require a narrow, documented diagnosis cost more. The full ledger on this page lists every tracked tort.
- How do I know if my mass tort lead vendor is overcharging?
- Run the benchmark test. Take your actual spend with one vendor over 90 days and divide it by the retainers signed from that vendor's leads, isolating the vendor rather than the tort. Compare the result with the tort's band in the current ledger. If your CPR sits more than 35% above the band and you cannot find an intake problem on your side, the vendor is either pricing above market or delivering under-qualified leads. Ask for a retainer-rate guarantee or CPR-ceiling pricing; vendors confident in their leads will engage.
- Should I track cost per signed retainer per vendor or per tort?
- Both, at the intersection: CPR per vendor, per tort, per quarter. A vendor-only average hides tort-specific quality differences, and a tort-only average hides vendor-specific ones. A vendor can be the cheapest source for one tort and the most expensive for another, and only the matrix shows where each vendor's spend belongs.
- What is falloff, and how does it change cost per signed retainer?
- Falloff is the share of claimants who sign a retainer and then disengage before medical records return or the case files. Every fallen-off retainer raises real CPR: a 20% falloff rate means a firm paid for 100 retainers and kept 80, so its true CPR is 25% higher than a raw signed count suggests. These benchmarks count only retainers that survive the 30-day falloff window, which is why they read higher than CPR figures computed on raw signed counts.
How to cite this page
Suggested citation:
Mass Tort Marketing Agency. "Mass tort cost per signed retainer benchmarks." Q1 2026 CPR Benchmark, published April 24, 2026. https://www.masstortmarketingagency.com/benchmarks
- Canonical URL:
- https://www.masstortmarketingagency.com/benchmarks
- License:
- CC BY 4.0 — reuse permitted with attribution to Mass Tort Marketing Agency CPR Benchmark, https://www.masstortmarketingagency.com/benchmarks/
Citing a number that must stay stable? Point at a dated snapshot instead of the live page — snapshot files never change.